STOCK TITAN

RxSight (RXST): Millennium entities, Israel Englander report 7.3% ownership stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

RxSight, Inc. is reported to have 3,030,287 shares of its common stock beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, representing 7.3% of the class as of June 30, 2026. Each reporting person lists 0 shares with sole voting or dispositive power and 3,030,287 shares with shared voting and shared dispositive power. The securities are held by entities subject to voting control and investment discretion of Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander, and the reporting persons state that this description should not by itself be construed as an admission of beneficial ownership. A Joint Filing Agreement dated August 3, 2026 is included as an exhibit.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 3,030,287 shares Common stock beneficially owned as reported on the cover pages
Percent of class 7.3% Percentage of RxSight common stock class reported as beneficially owned
Shared voting power 3,030,287 shares Shares over which each reporting person has shared power to vote or direct the vote
Shared dispositive power 3,030,287 shares Shares over which each reporting person has shared power to dispose or direct disposition
As-of date 06/30/2026 Date associated with the reported ownership information
Joint Filing Agreement date August 3, 2026 Date of Exhibit I Joint Filing Agreement among the reporting persons
beneficially owned financial
"Amount beneficially owned: See response to Item 9 on each cover page."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 3,030,287.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 3,030,287.00"
disposition of financial
"Sole power to dispose or to direct the disposition of:"
Joint Filing Agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of August 3, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stake in RxSight, Inc. (RXST) is reported in this Schedule 13G/A?

The filing reports 3,030,287 shares of RxSight common stock beneficially owned, representing 7.3% of the class as of June 30, 2026. All such shares are reported with shared, not sole, voting and dispositive power.

Who are the reporting persons in the RxSight (RXST) Schedule 13G/A amendment?

The reporting persons are Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. They jointly report beneficial ownership and have executed a Joint Filing Agreement dated August 3, 2026.

How much voting power over RxSight (RXST) shares do the reporting persons claim?

Each reporting person lists 0 shares with sole voting power and 3,030,287 shares with shared voting power. They also report the same number for shared dispositive power, indicating control is exercised jointly through related entities.

Do the Millennium entities and Israel A. Englander admit full beneficial ownership of RxSight (RXST) shares?

They state the securities are held by entities under their voting control or investment discretion but clarify this should not be construed as an admission of beneficial ownership of those securities by them individually.

What exhibit accompanies this RxSight (RXST) Schedule 13G/A filing?

The filing includes Exhibit I: Joint Filing Agreement dated August 3, 2026, among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, confirming they are making a joint ownership filing.





78349D107

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/03/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/03/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:08/03/2026
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of August 3, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.